Literature DB >> 25060384

Tubular carcinoma of the breast: axillary involvement and prognostic factors.

Vivienne Lea1, Laurence Gluch1,2, Catherine W Kennedy2, Hugh Carmalt1,2, David Gillett2.   

Abstract

BACKGROUND: Tubular carcinoma (TC) of the breast has a very favourable prognosis. The role for axillary staging in small TC was questioned. This study investigated the frequency of axillary metastases and prognostic factors in pure TC of the breast. It involved a retrospective review of prospectively collected data.
METHODS: A consecutive series of patients presenting to The Strathfield Breast Centre (TSBC) between 1988 and 2011 were reviewed. Only pure TC was included. Information collected included demographics, surgery, pathology, adjuvant therapy and survival.
RESULTS: Pure TC accounted for 146 out of 6110 cases of operable breast cancer. Ninety-five per cent were node negative (micrometastases and isolated tumour cells excluded). Ninety-eight per cent of those with known oestrogen receptor status were oestrogen receptor positive. Median tumour size was 10 mm (range 1-52 mm). Ten-year survival was 97%. Twelve per cent of patients had more than one tumour (either ipsilateral or contralateral). Eight patients had recurrent disease. All were node negative. Three of these patients died of their disease.
CONCLUSION: Axillary metastases are uncommon in pure TC. Recurrent disease is not readily predicted by tumour size or node status.
© 2014 Royal Australasian College of Surgeons.

Entities:  

Keywords:  axillary metastasis; prognosis; tubular breast carcinoma

Mesh:

Year:  2014        PMID: 25060384     DOI: 10.1111/ans.12791

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

1.  Pure and Mixed Tubular Carcinoma of the Breast: Mammographic Features, Clinicopathological Characteristics and Prognostic Analysis.

Authors:  Chanjuan Wen; Weimin Xu; Genggeng Qin; Hui Zeng; Zilong He; Sina Wang; Zeyuan Xu; Mengwei Ma; Zhendong Luo; Weiguo Chen
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

2.  Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Feng-Yan Li; Yong-Xiong Chen; Zhen-Yu He
Journal:  Front Oncol       Date:  2018-05-30       Impact factor: 6.244

3.  Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study.

Authors:  Wen-Wen Zhang; San-Gang Wu; Yi-Hong Ling; Jia-Yuan Sun; Zhi-Qing Long; Xin Hua; Yong Dong; Feng-Yan Li; Zhen-Yu He; Huan-Xin Lin
Journal:  Cancer Manag Res       Date:  2018-10-11       Impact factor: 3.989

4.  The effects of postoperative radiotherapy on survival outcomes in patients under 65 with estrogen receptor positive tubular breast carcinoma.

Authors:  Jian-Xian Chen; Wen-Wen Zhang; Yong Dong; Jia-Yuan Sun; Zhen-Yu He; San-Gang Wu
Journal:  Radiat Oncol       Date:  2018-11-20       Impact factor: 3.481

5.  The Role of Axillary Lymph Node Dissection in Tubular Carcinoma of the Breast: A Population Database Study.

Authors:  Shuang-Long Chen; Wen-Wen Zhang; Jun Wang; Jia-Yuan Sun; San-Gang Wu; Zhen-Yu He
Journal:  Med Sci Monit       Date:  2019-01-31

Review 6.  Rare epithelial breast cancer: surgery and adjuvant therapy.

Authors:  Aida Abdelwahed; Muneer Ahmed
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.